Investment
Features
FeesSafety
Academy
More
Pluang+

Research shows VeroSource's MyHealth app boosts patient empowerment; HEALWELL's DARWEN AI gains global recognition.

Market News
06 Oct 2026
Newsfile Corp
View Source
Bullish
Research shows VeroSource's MyHealth app boosts patient empowerment; HEALWELL's DARWEN AI gains global recognition.

Peer-reviewed research published in the Journal of Medical Internet Research found that VeroSource's MyHealth patient app significantly improves patient empowerment and healthcare engagement by reducing unnecessary calls, travel, and duplicate clinical interactions. The app, used in New Brunswick, allows secure access to personal health data, helping patients take a more active role in their care. Additionally, HEALWELL AI's DARWEN™ AI abstract was selected for the prestigious HealthAI Global Governance Forum 2026, highlighting its trusted and responsible AI governance in healthcare. These developments underscore HEALWELL's commitment to advancing digital health and AI solutions that enhance patient experiences and system efficiency.

HEALWELL AI research update offers context for healthcare technology interest. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 06, 2026 16:41 WIB: 69 of 100 priced US health stocks rose today. Notable movers include FLNA at USD 0.90 (+3.45%, 37 days typical hold, 92% buy orders), AMPH at USD 24.65 (-2.84%, 16 days typical hold), and TWST at USD 210.30 (+2.59%, 27 days typical hold, 92% sell orders).

More News

Costco shares drop 10% in 6 months while S&P 500 rises 17%, raising value questions below $900.

Costco shares drop 10% in 6 months while S&P 500 rises 17%, raising value questions below $900.

Over the past six months, Costco's stock has fallen by 10%, contrasting with the S&P 500's 17% gain. This decline has sparked debate on whether Costco's shares, now trading under $900, represent a buying opportunity. Investors are weighing if the pri...

Analyst Insights
Neutral
3 hours ago
IceCure Medical adds Legacy Health to U.S. study on cryoablation for low-risk breast cancer

IceCure Medical adds Legacy Health to U.S. study on cryoablation for low-risk breast cancer

IceCure Medical has expanded its U.S. clinical network for the ChoICE Study by adding Legacy Health in Oregon as a new site. The study evaluates the safety and effectiveness of ProSense® cryoablation, a minimally invasive treatment for low-risk breas...

Market News
Bullish
4 hours ago
Palantir's stock jumps 60% in Q3, its best quarter in over a year, but high valuation demands flawless growth.

Palantir's stock jumps 60% in Q3, its best quarter in over a year, but high valuation demands flawless growth.

Palantir Technologies saw its stock rise 60.3% in the third quarter, marking its strongest quarterly gain since mid-2025, driven by a 93% revenue increase to $1.935 billion and a 149% jump in U.S. commercial revenue. Despite this surge, Palantir is o...

Company Fundamentals
Bullish
4 hours ago
Nike shares hit worst year but long-term investors see buying opportunity amid turnaround hopes

Nike shares hit worst year but long-term investors see buying opportunity amid turnaround hopes

Nike shares are performing poorly this year, reflecting investor skepticism due to the company's struggling operating results. Despite the negative sentiment, analyst Justin Purohit believes that long-term investors could benefit from holding onto or...

Analyst Insights
Bullish
4 hours ago
Cardano price nears $0.28 resistance with rising leverage and whale activity amid new RealFi launch.

Cardano price nears $0.28 resistance with rising leverage and whale activity amid new RealFi launch.

Cardano's ADA price climbed to around $0.279, approaching the $0.28 resistance level after gaining nearly 9% in a week. The rally is supported by increased derivatives open interest and whale transactions, indicating new leveraged bets entering the m...

Technical Signals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App